Pediatrics and Healthcare

Biography

Dr Philippe Auby, a board-certified adult, child and adolescent psychiatrist with 25 years of experience in the pharmaceutical industry.Since 2001, Philippe has worked within the international environment, leading worldwide clinical development, directing global strategic decisions and interacting with regulatory bodies in the U.S., EU and Japan.In June 2016, Philippe became CEO, president, and board member of Otsuka Europe Development and Commercialisation, a UK-based company. Philippe prepared the company for Brexit, and in January 2019, became CEO & President of Otsuka Pharmaceutical Development & Commercialisation – Europe, a German-based company. Philippe also led the organisation successfully through the pandemic. He was a valued participant in Otsuka global strategic meetings in Japan and was a voting member of Otsuka global quality, regulatory and safety governance body. Previously, Philippe worked at Otsuka's Princeton, N.J. office as executive director-CNS for Abilify. He led a comprehensive and highly successful paediatric programme in schizophrenia and bipolar disorder, obtaining paediatric indications and paediatric exclusivity for Abilify in the U.S.He began his pharmaceutical industry career at the French headquarters of Eli Lilly and Bristol-Myers Squib, where he served as clinical research physician - CNS Department, and clinical research director neuroscience, respectively, before moving to Bristol-Myers Squib' European Headquarters in Belgium and shortly becoming Head of BMS Neuroscience Europe.

Research Interest

Paediatrics and Mental Health